Zealand Pharma A/S | ZEAL - Ordinary Share Capital


Zealand Pharma A/S reported 70.66M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.49M 108K Jun/2026
Dianthus Therapeutics USD 54.8M 215.59K Jun/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
IQVIA Holdings USD 164.8M 200K Sep/2026
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.62M 13K Sep/2026
Revvity USD 111.59M 43K Sep/2026
Tectonic Therapeutic USD 19.24M 404.78K Jun/2026
Tilray USD 116.52M 5.01M Sep/2025
Viatris USD 1.15B 8.79M Sep/2026
Xeris Pharmaceuticals USD 173.59M 1.03M Jun/2026
Zealand Pharma A/S 70.66M 53K Mar/2026